We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

AMS BIOTECHNOLOGY (EUROPE)

AMS Biotechnology (Europe) Ltd. provides cutting-edge life science technology, products and services for research and... read more Featured Products: More products

Download Mobile App




New ELISA Kit Measures Drug-Induced DNA Breaks

By LabMedica International staff writers
Posted on 07 Sep 2014
Print article
Image: H2AX foci following gamma irradiation for measurement of DNA (Photo courtesy of the [US] National Institutes of Health).
Image: H2AX foci following gamma irradiation for measurement of DNA (Photo courtesy of the [US] National Institutes of Health).
A gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks through the detection of the phosphorylated histone, gamma-H2AX, is now available for drug developers as well as biotech and other life science researchers.

The ubiquitous histone H2AX is a 14-kDa member of the H2A histone family that contains an evolutionarily conserved SQ motif at the C-terminus in eukaryotes.

Serine 139 within this motif becomes rapidly phosphorylated by kinases to yield a form known as gamma-H2AX in response to double-strand DNA damage and apoptosis.

There are over 21 anticancer drugs that are known to result in gamma-H2AX formation. As a result, gamma-H2AX is an ideal marker to measure molecular responses to a large number of drugs. While many of these drugs have already received regulatory approval, and are currently being used to manage various types of cancers, they are the subject of ongoing clinical studies to evaluate their efficacy when used alone or in combination with molecularly targeted drugs.

While methods such as Western blots and immunohistochemistry are widely used to detect gamma-H2AX, results are difficult to validate to regulatory standards, and the ELISA method is the most quantifiable and easiest assay to validate.

The new AMS Biotechnology (Abingdon, United Kingdom) pharmacodynamic HT gamma-H2AX assay measures gamma-H2AX levels in cellular extracts and phosphorylation of H2AX in response to therapeutic intervention. This assay documents differences in gamma-H2AX levels in human peripheral blood mononuclear cells, cultured cells, tissue biopsies, and is expected to be useful in future clinical trials providing one of many needed tools to enable hypothesis-driven preclinical drug design strategies.

The ELISA test utilizes immobilized gamma-H2AX antibodies in the wells of a 96-well plate that capture gamma-H2AX from sample lysates. Incubation with a H2AX detecting antibody, followed by addition of a goat anti-mouse HRP (horseradish peroxidase) conjugate and a chemiluminescent HRP substrate yields relative light units (RLU) that directly correlate with the amount of gamma-H2AX in the sample.

Related Links:

AMS Biotechnology


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Automated Cell Counter
QuadCount
New
Laboratory Electric Thermostat
DNP-9025A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.